Ladiva

Raspberry leaf dry extract, the active ingredient in Ladiva, is a herbal presented as a dry extract for oral use. It is traditionally associated with women’s health and mild digestive support.\n\nGNH India supplies Ladiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ladiva, containing raspberry leaf dry extract, is traditionally used in the context of women’s health and mild digestive support.\n\nMenstrual discomfort: may help alleviate cramping and promote comfort.\nPregnancy support: may assist uterine tone during early gestation.\nMild digestive upset: may provide soothing effect on the gastrointestinal tract.

Adverse reactions reported with raspberry leaf extracts are generally mild and infrequent.\n\nCommon Side Effects:\n- Mild gastrointestinal upset such as nausea or stomach discomfort.\n- Light‑headedness or transient dizziness.\n- Skin irritation or mild rash at the site of contact.\n\nSerious or Rare Side Effects:\n- Allergic reactions including swelling of the face, lips or throat.\n- Anaphylactic shock requiring immediate medical attention.\n- Hepatic dysfunction manifested by jaundice or elevated liver enzymes.

When considering raspberry leaf dry extract, certain precautions are advisable.\n\nAvoid use if known hypersensitivity to raspberry or related plants: discontinue immediately.\nPregnant or breastfeeding individuals: consult a healthcare professional before use.\nPatients on anticoagulant therapy: monitor clotting parameters closely.\nIndividuals with liver disease: use under medical supervision.\nStore at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Raspberry leaf dry extract may interact with several medication classes.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin): increased bleeding risk.\n- Antiplatelet agents (e.g., aspirin, clopidogrel): additive antithrombotic effect.\n\nModerate Interactions (Monitor Closely):\n- Hormonal contraceptives: potential reduction in efficacy.\n- Diabetes medications: possible alteration of blood‑glucose control.\n- Sedatives or CNS depressants: may enhance drowsiness.